D-Biotin Encyclopedia — Scientific Background

What Is D-Biotin?

D-Biotin (CAS 58-85-5), also known as vitamin B7, vitamin H, coenzyme R, or (3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazolevaleric acid, is a water-soluble B-complex vitamin with the molecular formula C₁₀H₁₆N₂O₃S and a molecular weight of 244.31 g/mol. The compound is a bicyclic derivative consisting of an imidazolidone ring fused to a tetrahydrothiophene ring bearing a valeric acid side chain. D-Biotin occurs as white to off-white crystalline powder with a melting point of 232–233°C, a specific rotation of +89° to +93°, and an isoelectric point of 3.5.

Physiological Functions of D-Biotin

D-Biotin is a critical nutrient with several essential physiological roles:

• Carboxylase Cofactor — Biotin is the essential cofactor for four biotin-dependent carboxylases in humans: acetyl-CoA carboxylase (fatty acid synthesis), pyruvate carboxylase (gluconeogenesis), propionyl-CoA carboxylase (amino acid catabolism), and β-methylcrotonyl-CoA carboxylase (leucine catabolism). These enzymes play important roles in lipogenesis, gluconeogenesis, and amino acid metabolism.

• Energy Metabolism — Biotin helps turn the carbohydrates, fats, and proteins in food into energy the body needs. It contributes to normal energy-yielding metabolism and supports the function of the mitochondrial electron transport chain.

• Fatty Acid Synthesis — Acetyl-CoA carboxylase, a biotin-containing enzyme, plays a critical role in the control of fatty acid biosynthesis. Biotin functions as a CO₂ carrier in this enzymatic reaction.

• Gluconeogenesis — Pyruvate carboxylase, a biotin-dependent enzyme, synthesizes oxaloacetate from pyruvate and bicarbonate, requiring ATP. This reaction is essential for glucose production during fasting.

• Amino Acid Catabolism — Propionyl-CoA carboxylase and β-methylcrotonyl-CoA carboxylase are biotin-dependent enzymes involved in the catabolism of amino acids including isoleucine, valine, methionine, threonine, and leucine.

• Gene Expression Regulation — Biotin is covalently attached to biotin-dependent carboxylases by biotin protein ligase (holocarboxylase synthase in mammals) to form active holocarboxylase. Additionally, biotin affects gene expression through histone biotinylation and regulation of transcription factors.

Mechanisms of Action

Biotin-Dependent Carboxylase System

The biotin-dependent carboxylase system is the primary mechanism through which biotin exerts its metabolic effects. Biotin is covalently attached to a specific lysine residue of the carboxyl carrier protein (CCP) domain of each carboxylase by holocarboxylase synthase. The biotinyl prosthetic group acts as a mobile carboxyl carrier that oscillates between the carboxylation and transcarboxylation sites on biotin carboxylase and carboxyltransferase, respectively. In the acetyl-CoA carboxylase reaction, biotin carboxylase catalyzes the stoichiometric carboxylation of the carboxyl carrier protein in the presence of ATP, Mg²⁺, and HCO₃⁻, and carboxyltransferase carries out net transcarboxylation from the carboxylated carboxyl carrier protein to acetyl-CoA to form malonyl-CoA.

SMVT Transport and liposomal Bypass

Biotin absorption occurs primarily in the small intestine through the sodium-dependent multivitamin transporter (SMVT), which is saturable and exhibits dose-dependent absorption kinetics. At higher doses, SMVT becomes saturated, and absorption efficiency declines. Liposomal encapsulation offers a biomimetic delivery mechanism that bypasses SMVT saturation through non-saturable passive diffusion, endocytosis, and lymphatic uptake. Liposomal biotin formulations significantly improve oral absorption by substantially increasing solubility and protecting the vitamin from gastric degradation and first-pass hepatic metabolism.

The Bioavailability Challenge

Despite its essential physiological functions, conventional oral D-biotin presents significant bioavailability challenges. The compound has low aqueous solubility (approximately 22 mg/100 mL at 25°C), which limits its dissolution rate and absorption following oral administration. D-Biotin absorption occurs primarily through the saturable SMVT transporter, and at higher doses, this transporter becomes saturated, limiting systemic bioavailability.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. Nano-liposomal biotin formulations have been specifically developed for stabilizing and increasing the solubility of biotin, a water-soluble active material with low solubility. Biotin nano-liposomes with improved solubility and precipitation problems have been successfully manufactured, with particle sizes of 100–250 nm and zeta potentials of −80 to −30 mV.

Liposomal D-Biotin

Liposomal encapsulation of D-biotin provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the D-biotin molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:

• Significantly improves oral absorption by substantially increasing solubility

• Bypasses SMVT saturation through non-saturable passive diffusion, endocytosis, and lymphatic uptake

• Protects D-biotin from gastric degradation and first-pass hepatic metabolism

• Provides sustained release for prolonged carboxylase cofactor activity

• Achieves particle sizes of 100–250 nm with zeta potentials of −80 to −30 mV

Clinical Evidence

Hair, Skin, and Nail Health — Randomized Controlled Trial

A randomized, double-blind, placebo-controlled clinical trial enrolled 105 participants, with 97 completing the 90-day study. Participants received either placebo, a botanical extract standardized for biotin (1.25 mg orally administered), or a botanical extract standardized for biotin with silica (1.25 mg biotin with 21.75 mg silica orally administered). In the post-90-day evaluation, hair fall reduced to 20.61 ± 14.39 (p < 0.001) in the biotin group and 15.71 ± 10.8 (p < 0.001) in the biotin with silica group. Hair growth rate increased by 0.55 mm/day (p < 0.0001) in the biotin group and 0.57 mm/day (p < 0.0001) in both groups with silica. Nail roughness reduced to 0.09 ± 0.29 (p < 0.0001) in the biotin group and 0.06 ± 0.25 (p < 0.0001) in the biotin with silica group. Skin elasticity increased to 0.15 ± 0.06 (p < 0.0001) in the biotin group and 0.17 ± 0.12 (p < 0.0001) in the biotin with silica group. No adverse events were reported.

Biotin Deficiency

Biotin deficiency is very rare in the United States. Biotin deficiency can cause thinning hair and loss of body hair; a rash around the eyes, nose, mouth, and anal area; pinkeye; high levels of acid in the blood and urine; seizures; skin infection; brittle nails; and nervous system disorders. Symptoms of biotin deficiency in infants include weak muscle tone, sluggishness, and delayed development. D-Biotin supplementation effectively prevents and treats biotin deficiency.

Energy Metabolism

Biotin helps turn the carbohydrates, fats, and proteins in food into energy the body needs. It contributes to normal energy-yielding metabolism and supports mitochondrial function through its role as a carboxylase cofactor.

Safety and Regulatory

D-Biotin has a well-established safety profile. It is a water-soluble vitamin, and excess amounts are excreted in the urine. No tolerable upper intake level (UL) has been established for biotin due to its low toxicity.

Regulatory Status:

• United States — D-Biotin is regulated as a dietary supplement ingredient and food additive. It is Generally Recognized As Safe (GRAS) for use in food and dietary supplements. It is monographed in the USP with an assay specification of 98.0%–102.0% on dried basis.

• European Union — D-Biotin is authorized as a vitamin and mineral substance which may be used in the manufacture of food supplements. It is monographed in the European Pharmacopoeia and Food Chemicals Codex (FCC).

• Global Standards — D-Biotin is monographed in the USP, European Pharmacopoeia, Japanese Pharmacopoeia, and Food Chemicals Codex (FCC) with an assay specification of 98.0%–102.0% on dried basis. It is available with Halal and Kosher certifications.

Precautions: D-Biotin is generally well tolerated. High-dose biotin supplementation (≥5 mg/day) may interfere with certain laboratory tests, including immunoassays for thyroid hormones, cardiac troponin, and other biomarkers, potentially leading to falsely low or falsely high results. Individuals should inform their healthcare provider about biotin supplementation before undergoing laboratory testing. Pregnant or lactating women and children should consult a healthcare professional before use.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

329$/KG

269$/KG

89$/KG